Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09
Perez OA et al. – Current therapies are primarily directed against the formation of these antibodies by suppression of the immune system, and are associated with significant adverse events. As our understanding of the pathophysiology of pemphigus increases, newer therapies have been proposed and evaluated. These novel therapies include intravenous immunoglobulin, plasmapheresis, immunoadsorption, extracorporeal photochemotherapy, biological agents, as well as experimental therapies such as cholinergic receptor agonists, Dsg3 peptides and a p38 mitogen–activated protein kinase inhibitor. Current limitations to the widespread use of these therapies include cost, a lack of consistent data regarding their benefit, limited availability, and the experimental nature of some of the treatments. This review highlights the latest case reports and studies that employ established as well as new therapeutics in a novel way to treat this rare, but serious, disorder.
Related Articles
Subcorneal Pustular Dermatosis-Type IgA Pemphigus With Autoantibodies to Desmocollins 1, 2, and 3
Archives of Dermatology, 10/22/09
Relevance Score: 88%
Treatment of pemphigus vulgaris and pemphigus foliaceus
Expert Review of Dermatology, 10/13/09
Relevance Score: 88%
Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype
Clinical and Experimental Dermatology, 11/10/09
Relevance Score: 85%
Demonstration of pemphigus-specific immunofluorescence pattern by direct immunofluorescence of plucked hair
International Journal of Dermatology, 10/28/09
Relevance Score: 85%
Efficacy of Dapsone in the Treatment of Pemphigus and Pemphigoid: Analysis of Current Data
American Journal of Clinical Dermatology, 10/20/09
Relevance Score: 85%
Today in Allergy/Immunology...keeping you current
Receive free subspecialty "5-minute updates" via email
The role of female sex hormones in the development and severity of allergic and non-allergic asthma
Clinical and Experimental Allergy, 11/20/09
Current and future immunotherapy in myasthenia gravis
Future Neurology, 11/20/09
Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis
Archives of Neurology, 11/19/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis
Journal of Rheumatology, 11/20/09
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Use of Oral N-Acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress: Towards a Novel Paradigm for Melanoma Chemoprevention
Clinical Cancer Research, 11/20/09
BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naevi
British Journal of Dermatology, 11/20/09
Iatrogenic Bullae Following Cupping Therapy
Journal of Alternative and Complementary Medicine, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


